WITHHOLDING UNFAVOURABLE RESULTS IN DRUG COMPANY SPONSORED CLINICAL TRIALS
暂无分享,去创建一个
J. Rask-Madsen | K. Lauritsen | T. Havelund | L. Laursen | K. Lauritsen | T. Havelund | L. S. Laursen | J. Rask-Madsen
[1] T. Louis,et al. Critical issues in the conduct and interpretation of clinical trials. , 1983, Annual review of public health.
[2] H. Toutenburg. Fleiss, J. L.: Statistical Methods for Rates and Proportions. John Wiley & Sons, New York‐London‐Sydney‐Toronto 1973. XIII, 233 S. , 1974 .